Leong Natalie Ee Mun 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Aug 25, 2025
Insider Transaction Report
Form 4
Leong Natalie Ee Mun
Director
Transactions
- Award
Share Option (Right to Buy)
2025-08-21+4,105→ 4,105 totalExercise: $9.07Exp: 2035-05-28→ ADS (4,105 underlying)
Footnotes (3)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
- [F2]The option grant was approved by the Compensation Committee and the Board on May 29, 2025, subject to shareholder approval. The Company's shareholder's approved this option grant on August 21, 2025.
- [F3]The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.